Heartbeam (BEAT) vs Nephros (NEPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Nephros (NEPH) has outperformed Heartbeam (BEAT) over the past year, losing 43.7% versus a loss of 69.1%. Nephros is the larger company by market cap ($34.8 million vs $30.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BEAT | NEPH |
|---|---|---|
| Share price | $0.543 | $3.20 |
| Market cap | $30.60M | $34.75M |
| 1-day change | -7.02% | +5.96% |
| YTD return | -77.38% | -34.43% |
| 1-year return | -69.15% | -43.66% |
| 5-year return | — | -58.76% |
| P/E ratio (TTM) | — | 20.00 |
| Forward P/E | — | 15.24 |
| EPS (TTM) | $-0.50 | $0.16 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.00 | $6.42 |
| 52-week low | $0.355 | $2.66 |
| Distance from 52-week high | -86.42% | -50.16% |
| Average volume | 7.35M | 25.25K |
| Shares outstanding | 56.35M | 10.86M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NEPH has outperformed BEAT by 25.5 percentage points over the past year.
BEAT vs NEPH FAQ
Which is bigger, Heartbeam or Nephros?
Nephros (NEPH) is larger, with a market capitalization of $34.75M compared with $30.60M for Heartbeam (BEAT).
Which stock has performed better over the past year, BEAT or NEPH?
NEPH returned -43.66% over the past 12 months, compared with -69.15% for BEAT (price return, excluding dividends). Past performance does not predict future results.
Are Heartbeam and Nephros in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.